Reversal of tolerance to human MUC1 antigen in MUC1 transgenic mice immunized with fusions of dendritic and carcinoma cells
AUTOR(ES)
Gong, Jianlin
FONTE
The National Academy of Sciences
RESUMO
Immunological unresponsiveness established by the elimination or anergy of self-reactive lymphocyte clones is of importance to immunization against tumor-associated antigens. In this study, we have investigated induction of immunity against the human MUC1 carcinoma-associated antigen in MUC1 transgenic mice unresponsive to MUC1 antigen. Immunization of adult MUC1 transgenic mice with irradiated MUC1-positive tumor cells was unsuccessful in reversing unresponsiveness to MUC1. By contrast, fusions of dendritic cells with MUC1-positive tumor cells induced cellular and humoral immunity against MUC1. Immunization with the dendritic cell fusions that express MUC1 resulted in the rejection of established metastases and no apparent autoimmunity against normal tissues. These findings demonstrate that unresponsiveness to the MUC1 tumor-associated antigen is reversible by immunization with heterokaryons of dendritic cells and MUC1-positive carcinoma cells.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=27657Documentos Relacionados
- Selectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUC1 antigen
- Significance of MUC1 and MUC2 mucin expression in colorectal cancer.
- MUC1 and MUC2 mucins in flat and polypoid colorectal adenomas.
- Activation of antitumor cytotoxic T lymphocytes by fusions of human dendritic cells and breast carcinoma cells
- Cystic fibrosis mice lacking Muc1 have reduced amounts of intestinal mucus.
